Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema

The prognosis of cirrhotic patients with hepatic edema is poor. Although several short‐term predictors of tolvaptan (novel diuretic agent) treatment for such patients have been reported, the factors related to long‐term survival are still unclear.

[1]  Y. Kida.  Positive Response to Tolvaptan Treatment Would Be a Good Prognostic Factor for Cirrhotic Patients with Ascites , 2019, Digestive Diseases.

[2]  I. Sakaida,et al.  Analysis of tolvaptan non‐responders and outcomes of tolvaptan treatment of ascites , 2018, Journal of gastroenterology and hepatology.

[3]  M. Shimizu,et al.  Effect of loop diuretics on skeletal muscle depletion in patients with liver cirrhosis , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  H. Weng,et al.  Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia , 2018, BMC Gastroenterology.

[5]  T. Kondo,et al.  The Effect of Loop Diuretics on Sarcopenia and Long-Term Prognosis in Patients with Refractory Hepatic Ascites Treated with Tolvaptan , 2018 .

[6]  A. Tsubota,et al.  Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema , 2018, Journal of gastroenterology and hepatology.

[7]  T. Sugiyama,et al.  Survival Benefit of Tolvaptan for Refractory Ascites in Patients with Advanced Cirrhosis , 2018, Digestive Diseases.

[8]  H. Yoshiji,et al.  Response criteria of tolvaptan for the treatment of hepatic edema , 2018, Journal of Gastroenterology.

[9]  H. Hidaka,et al.  Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study , 2017, World journal of gastroenterology.

[10]  H. Yoshiji,et al.  Predictive parameter of tolvaptan effectiveness in cirrhotic ascites , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

[11]  M. Taniai,et al.  Response to tolvaptan and its effect on prognosis in cirrhotic patients with ascites , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

[12]  A. Ido,et al.  Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

[13]  N. Fujii,et al.  Loop diuretics affect skeletal myoblast differentiation and exercise-induced muscle hypertrophy , 2017, Scientific Reports.

[14]  N. Enomoto,et al.  Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio , 2017, PloS one.

[15]  H. Hidaka,et al.  Close correlation between urinary sodium excretion and response to tolvaptan in liver cirrhosis patients with ascites , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

[16]  M. Kurosaki,et al.  Effectiveness and safety of tolvaptan in liver cirrhosis patients with edema: Interim results of post‐marketing surveillance of tolvaptan in liver cirrhosis (START study) , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[17]  Y. Minami,et al.  Clinical Factors Predicting the Effect of Tolvaptan for Refractory Ascites in Patients with Decompensated Liver Cirrhosis , 2016, Digestive Diseases.

[18]  A. Tsubota,et al.  Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients. , 2016, World journal of gastroenterology.

[19]  M. Kurosaki,et al.  Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites , 2016, Journal of Gastroenterology.

[20]  K. Sugano,et al.  Evidence-based clinical practice guidelines for liver cirrhosis 2015 , 2016, Journal of Gastroenterology.

[21]  K. Okita,et al.  Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double‐blind, placebo‐controlled trial , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

[22]  F. Wong.  Management of ascites in cirrhosis , 2012, Journal of gastroenterology and hepatology.

[23]  S. Saab,et al.  TIPS versus paracentesis for cirrhotic patients with refractory ascites. , 2006, The Cochrane database of systematic reviews.

[24]  R. Schrier,et al.  Ascites and Renal Dysfunction in Liver Disease , 2005 .

[25]  V. Arroyo,et al.  Refractory Ascites , 2005, Digestive Diseases.

[26]  R. Moreau,et al.  The management of ascites in cirrhosis: Report on the consensus conference of the international Ascites club , 2003, Hepatology.

[27]  V. Arroyo.  Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment , 1999 .

[28]  L. Rossaro,et al.  Reinfusion of Concentrated Ascitic Fluid versus Total Paracentesis (A Randomized Prospective Trial) , 1997, Digestive Diseases and Sciences.

[29]  A. Rosemurgy,et al.  Peritoneovenous shunts in patients with intractable ascites: palliation at what price? , 1997, The American surgeon.

[30]  J. Schölmerich,et al.  Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis , 1996, Hepatology.

[31]  J. Llach,et al.  Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. , 1988, Gastroenterology.

[32]  W. Jiménez,et al.  Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. , 1987, Gastroenterology.

[33]  C. Sakamoto,et al.  Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial , 2010, Journal of Gastroenterology.

[34]  V. Arroyo,et al.  Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. , 2003, Journal of hepatology.

[35]  V. Arroyo,et al.  Compensated cirrhosis: Natural history and prognostic factors , 1987, Hepatology.